Futur obscur, idees clares. Cancer Immunologist.

Joined March 2010
Marcel Arias retweeted
What if doctors could use your own tumor to teach your immune system to destroy cancer? UCSF scientists may have found a way. By coating lab-grown immune cells with pieces of a patient’s own tumor, they trained T cells to recognize and attack the cancer. ucsf.edu/news/2026/08/432431…
10
36
2,116
A highlight from last week: Can routine archived clinical biopsies help predict treatment response in ulcerative colitis? doi.org/10.1172/JCI202488 @MikeKattahMD, @alexis_combes & team @UCSFMedicine applied spatial gene mapping to archived colitis biopsies, identifying immune cell neighborhoods that explain why some patients are resistant to vedolizumab and others respond well. @MayoClinic #Colitis #IBD
1
10
22
2,343
📢 PhD position open at #VHIO 🧑‍🔬 Join the Cell Engineering and Hematologic Immunotherapy Group, led by Pere Barba, and work on: 🧬 Cellular immunotherapy 🩸 CAR T-cell biology 🔬 Genomics 🎯 Translational cancer research 🗓️ Deadline: 26/06 Apply 👇 jobs.vhio.net/en/jobs/790106…
2
6
723
Marcel Arias retweeted
A painting of the end of meritocracy: A meeting of the two largest economies and not one woman at the table.
13,804
10,086
3,755
43,976
11,784,090
Marcel Arias retweeted
Intratumoral CD4+CD8+ T cells can serve as precursors to single positive T cells in vivo via Rag2 expression, suggesting that tumors act as extrathymic sites of T cell development @UCSF pnas.org/doi/10.1073/pnas.25…
2
20
1
89
6,556
Marcel Arias retweeted
Not only does UCSF's NIH-funded research advance health care and improve patients' lives, it has an estimated $18.7B ripple effect on the economy. The result is more innovative startups, more jobs, and stronger companies that hire workers nationwide. tiny.ucsf.edu/SavingLivesWit…
15
2
44
4,428
Marcel Arias retweeted
Review @JExpMed @lawfong CD4+ T cell dysfunction in cancer rupress.org/jem/article/222/…
22
1
95
6,387
Marcel Arias retweeted
La Vanguardia entrevista la investigadora de l'#IDIBAPS @GuedanS, finalista dels premis La Vanguardia de la ciencia.  La pots votar en aquest enllaç 👉f.mtr.cool/gahnvtuxow
1
5
20
1,442
Marcel Arias retweeted
🗞️Sònia Guedán (@GuedanS), cap de grup de l'#IDIBAPS, entre les 8️⃣ finalistes al premi Vanguardia de la Ciència Una iniciativa de @LaVanguardia i la @FCLP_Fundacio per visibilitzar dones científiques i reduir la bretxa de gènere en la recerca 👉f.mtr.cool/yyawblwnpe
3
7
509
New #JITC article: Impact of tumor localization on antitumor immunity with conditionally activated CTLA-4 blockade bit.ly/42zatca @MarcelArias @UCSF
3
16
946
🎭 This Friday, March 28, our #UCSF #improv group is hitting the stage at @TheLostChurchSF! A bunch of #scientists doing improv—what could go wrong? (Or very right 😄) Expect laughs, chaos, and a great show! 🎟️ Grab your tickets here: thelostchurch.my.salesforce-…
4
1
4
774
#StandUpForScience2025 if you'd like a healthier future for humanity
3
68
Me hace mucha ilusión haber recibido el reconocimiento al mejor artículo científico de 2024 junto a @GuedanS y @fara_bm durante el segundo #EncuentroInvestigadoresAECC. Fue una jornada increíble rodeada de colegas y amigos. Muchas gracias @contracancerINV por vuestro apoyo! 💚
🏆🔬 En el #EncuentroInvestigadoresAECC celebramos la excelencia en la investigación oncológica con los Reconocimientos AECC. ¡Felicidades a los ganadores! 1. Guillermo del Cárcer @GdC_CCCB_lab de @IIBmCSICUAM por su labor de divulgación científica 2. @amaia_cipitria de @biogipuzkoa por el mejor pitch de ideas innovadoras 2025 3. @a_diazguerra de @CNIC_CARDIO por el mejor artículo científico de 2024 de entre los adjudicatarios de Ayudas Predoctorales AECC. 4. @GuedanS, Alba Rodríguez y @fara_bm de @idibaps - @hospitalclinic por el mejor artículo científico de 2024 de entre los adjudicatarios de Ayudas Generales AECC #InvestigandoEnCáncer
1
3
27
937
In this fantastic collaboration with Abbvie we were able to find time-sensitive synergistic effects between immune checkpoint blockade and JAK1 inhibition in boosting T cell fitness against tumors in mice. Online today! insight.jci.org/articles/vie… @lawfong
1
1
4
217
Marcel Arias retweeted
Aram Lyu, Peiqi Ou, Helen Rizos, and Annette Paschen discuss "Cancer Immune Evasion" in a symposium at the AACR IO Conference on Discovery and Innovation in Cancer Immunology. #AACRIO25 @HelenRizos @AramLyu
3
1
16
1,913
A multi-institutional team led by @lawfong (former Co-Director of the PICI Center at @UCSF, now at @fredhutch) published a new PICI-funded study in @CCR_AACR exploring nivolumab-based combination therapies in metastatic castration-resistant prostate cancer (mCRPC). (1/3)
1
2
4
1,138